BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15562023)

  • 1. The common -866G/A polymorphism in the promoter region of the UCP-2 gene is associated with reduced risk of type 2 diabetes in Caucasians from Italy.
    Bulotta A; Ludovico O; Coco A; Di Paola R; Quattrone A; Carella M; Pellegrini F; Prudente S; Trischitta V
    J Clin Endocrinol Metab; 2005 Feb; 90(2):1176-80. PubMed ID: 15562023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects.
    Sesti G; Cardellini M; Marini MA; Frontoni S; D'Adamo M; Del Guerra S; Lauro D; De Nicolais P; Sbraccia P; Del Prato S; Gambardella S; Federici M; Marchetti P; Lauro R
    Diabetes; 2003 May; 52(5):1280-3. PubMed ID: 12716765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The -866A/A genotype in the promoter of the human uncoupling protein 2 gene is associated with insulin resistance and increased risk of type 2 diabetes.
    D'Adamo M; Perego L; Cardellini M; Marini MA; Frontoni S; Andreozzi F; Sciacqua A; Lauro D; Sbraccia P; Federici M; Paganelli M; Pontiroli AE; Lauro R; Perticone F; Folli F; Sesti G
    Diabetes; 2004 Jul; 53(7):1905-10. PubMed ID: 15220218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The frequent UCP2 -866G>A polymorphism protects against insulin resistance and is associated with obesity: a study of obesity and related metabolic traits among 17 636 Danes.
    Andersen G; Dalgaard LT; Justesen JM; Anthonsen S; Nielsen T; Thørner LW; Witte D; Jørgensen T; Clausen JO; Lauritzen T; Holmkvist J; Hansen T; Pedersen O
    Int J Obes (Lond); 2013 Feb; 37(2):175-81. PubMed ID: 22349573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association study of the -866G/A UCP2 gene promoter polymorphism with type 2 diabetes and obesity in a Tehran population: a case control study.
    Heidari J; Akrami SM; Heshmat R; Amiri P; Fakhrzadeh H; Pajouhi M
    Arch Iran Med; 2010 Sep; 13(5):384-90. PubMed ID: 20804304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between the UCP2 -866 G>A polymorphism, diabetes, and beta-blocker use among patients with acute coronary syndromes.
    Beitelshees AL; Finck BN; Leone TC; Cresci S; Wu J; Province MA; Fabbrini E; Kirk E; Zineh I; Klein S; Spertus JA; Kelly DP
    Pharmacogenet Genomics; 2010 Apr; 20(4):231-8. PubMed ID: 20145583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The -866G/A polymorphism in the promoter of the UCP2 gene is associated with risk for type 2 diabetes and with decreased insulin levels.
    Gomathi P; Samarth AP; Raj NBAJ; Sasikumar S; Murugan PS; Nallaperumal S; Selvam GS
    Gene; 2019 Jun; 701():125-130. PubMed ID: 30910560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uncoupling protein 2 promoter polymorphism -866G/A affects its expression in beta-cells and modulates clinical profiles of Japanese type 2 diabetic patients.
    Sasahara M; Nishi M; Kawashima H; Ueda K; Sakagashira S; Furuta H; Matsumoto E; Hanabusa T; Sasaki H; Nanjo K
    Diabetes; 2004 Feb; 53(2):482-5. PubMed ID: 14747301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of association of functional UCP2 -866G/A and Ala55Val polymorphisms and type 2 diabetes in the Chinese population based on a case-control study and a meta-analysis.
    Qin LJ; Wen J; Qu YL; Huang QY
    Genet Mol Res; 2013 Sep; 12(3):3324-34. PubMed ID: 24065674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uncoupling protein 2 -866G/A and uncoupling protein 3 -55C/T polymorphisms in young South African Indian coronary artery disease patients.
    Phulukdaree A; Moodley D; Khan S; Chuturgoon AA
    Gene; 2013 Jul; 524(2):79-83. PubMed ID: 23639961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of telomere length with type 2 diabetes, oxidative stress and UCP2 gene variation.
    Salpea KD; Talmud PJ; Cooper JA; Maubaret CG; Stephens JW; Abelak K; Humphries SE
    Atherosclerosis; 2010 Mar; 209(1):42-50. PubMed ID: 19889414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uncoupling protein 2 promoter polymorphism -866G/A affects peripheral nerve dysfunction in Japanese type 2 diabetic patients.
    Yamasaki H; Sasaki H; Ogawa K; Shono T; Tamura S; Doi A; Sasahara M; Kawashima H; Nakao T; Furuta H; Nishi M; Nanjo K
    Diabetes Care; 2006 Apr; 29(4):888-94. PubMed ID: 16567833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UCP2 -866G/A and Ala55Val, and UCP3 -55C/T polymorphisms in association with type 2 diabetes susceptibility: a meta-analysis study.
    Xu K; Zhang M; Cui D; Fu Y; Qian L; Gu R; Wang M; Shen C; Yu R; Yang T
    Diabetologia; 2011 Sep; 54(9):2315-24. PubMed ID: 21751002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A functional polymorphism in the promoter of UCP2 enhances obesity risk but reduces type 2 diabetes risk in obese middle-aged humans.
    Krempler F; Esterbauer H; Weitgasser R; Ebenbichler C; Patsch JR; Miller K; Xie M; Linnemayr V; Oberkofler H; Patsch W
    Diabetes; 2002 Nov; 51(11):3331-5. PubMed ID: 12401727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation in the UCP2-UCP3 gene cluster predicts the development of type 2 diabetes in healthy middle-aged men.
    Gable DR; Stephens JW; Cooper JA; Miller GJ; Humphries SE
    Diabetes; 2006 May; 55(5):1504-11. PubMed ID: 16644712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between UCP1 -3826A/G, UCP2 -866G/A, Ala55Val and Ins/Del, and UCP3 -55C/T polymorphisms and susceptibility to type 2 diabetes mellitus: case-control study and meta-analysis.
    de Souza BM; Brondani LA; Bouças AP; Sortica DA; Kramer CK; Canani LH; Leitão CB; Crispim D
    PLoS One; 2013; 8(1):e54259. PubMed ID: 23365654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variation in UCP2 (uncoupling protein-2) is associated with energy metabolism in Pima Indians.
    Kovacs P; Ma L; Hanson RL; Franks P; Stumvoll M; Bogardus C; Baier LJ
    Diabetologia; 2005 Nov; 48(11):2292-5. PubMed ID: 16167150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A polymorphism in the promoter of UCP2 gene modulates lipid levels in patients with type 2 diabetes.
    Reis AF; Dubois-Laforgue D; Bellanné-Chantelot C; Timsit J; Velho G
    Mol Genet Metab; 2004 Aug; 82(4):339-44. PubMed ID: 15308133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The uncoupling protein 2 -866G > a polymorphism is associated with the risk of ischemic stroke in Chinese type 2 diabetic patients.
    Chai Y; Gu B; Qiu JR; Yi HG; Zhu Q; Zhang L; Hu G
    CNS Neurosci Ther; 2012 Aug; 18(8):636-40. PubMed ID: 22613561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simple and rapid detection of uncoupling protein-2 - 866G/A polymorphism by mutagenically separated polymerase chain reaction.
    Zhang B; Tanaka H; Saku K
    Clin Chim Acta; 2004 Jun; 344(1-2):205-10. PubMed ID: 15149891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.